Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

NCT00648999 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: lopinavir/ritonavir

Sponsor

AbbVie (prior sponsor, Abbott)